Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LQDA Liquidia Technologies Inc

Trading 03-24 10:50:42 EDT

34.79

-0.71

-2.01%

High36.00	Low34.63	Vol134.34K
Open35.46	D1 Closing35.50	Amplitude3.86%
Mkt Cap3.07B	Tradable Cap2.13B	Total Shares88.11M
T/O4.71M	T/O Rate0.22%	Tradable Shares61.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":34.785,"timestamp":1774363840316,"preClose":35.5,"halted":0,"volume":134341,"delay":0,"changeRate":-0.02014084507042263,"floatShares":61270900,"shares":88114429,"eps":-0.800891,"marketStatus":"Trading","change":-0.715,"latestTime":"03-24 10:50:42 EDT","open":35.46,"high":36,"low":34.63,"amount":4713040.164424,"amplitude":0.038592,"askPrice":34.76,"askSize":5,"bidPrice":34.67,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.800891,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":35.5,"preHourTrading":{"tag":"盘前","latestPrice":36.2769,"preClose":35.5,"latestTime":"08:50 EDT","volume":14,"amount":505.08898999999997,"timestamp":1774356628852,"change":0.7769,"changeRate":0.021885,"amplitude":0.02442},"postHourTrading":{"tag":"盘后","latestPrice":35.513,"preClose":35.5,"latestTime":"19:03 EDT","volume":22736,"amount":807069.51,"timestamp":1774307033822,"change":0.013,"changeRate":0.000366,"amplitude":0.00338},"volumeRatio":0.625461,"impliedVol":1.4722,"impliedVolPercentile":0.7649},"requestUrl":"/m/hq/s/LQDA/tweets","defaultTab":"tweets","newsList":[{"id":"2620261635","title":"Liquidia (LQDA) Is Down 5.1% After Q4 Profitability And New Shelf Filings - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261635","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261635?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:04","pubTimestamp":1773860684,"startTime":"0","endTime":"0","summary":"In March 2026, Liquidia Corporation reported fourth-quarter 2025 revenue of US$92.02 million versus US$2.92 million a year earlier, shifting from a net loss to net income of US$14.56 million and delivering positive earnings per share from continuing operations.\nFor 2025 as a whole, revenue rose to US$158.32 million while the annual net loss narrowed to US$68.92 million, and on the same day Liquidia filed multiple shelf registrations covering common and preferred stock, debt securities,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/liquidia-lqda-is-down-51-after-q4-profitability-and-new-shel","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/liquidia-lqda-is-down-51-after-q4-profitability-and-new-shel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2620403589","title":"Liquidia Chief Human Resource Officer Sarah Krepp disposes of USD 617,918 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403589","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403589?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:34","pubTimestamp":1773779696,"startTime":"0","endTime":"0","summary":"Sarah Krepp, Chief Human Resource Officer of Liquidia, reported a disposal of 16,261 common shares at USD 38 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL48gyyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Liquidia Chief Human Resource Officer Sarah Krepp disposes of USD 617,918 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2620403307","title":"Liquidia Director Raman Singh Disposes of USD 720,828 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403307","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403307?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:33","pubTimestamp":1773779618,"startTime":"0","endTime":"0","summary":"Raman Singh, a director at Liquidia, reported disposing of 20,000 common shares at USD 36.04 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL1sRG1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2619273464","title":"Liquidia Technologies put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2619273464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619273464?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:55","pubTimestamp":1773672909,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Liquidia (LQDA) Technologies with 2,137 puts trading, or 1.1x expected. Most active are Apr-26 30 puts and Mar-26 20 puts, wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2617690631","title":"Liquidia Analysts Boost Their Forecasts After Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2617690631","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617690631?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:17","pubTimestamp":1772813851,"startTime":"0","endTime":"0","summary":"Liquidia Corp (LQDA) reported mixed Q4 results, with earnings missing estimates but sales beating expectations. Analysts have mixed opinions on stock.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51101305/liquidia-analysts-boost-their-forecasts-after-q4-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2617396846","title":"Liquidia rises 7.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617396846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617396846?lang=en_us&edition=fundamental","pubTime":"2026-03-06 23:06","pubTimestamp":1772809602,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) is up 7.7%, or $2.66 to $37.19. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-rises-7-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-rises-7-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"1133909924","title":"Stock Track | Liquidia Technologies Soars 5.01% Intraday on Multiple Analyst Buy Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1133909924","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133909924?lang=en_us&edition=fundamental","pubTime":"2026-03-06 22:44","pubTimestamp":1772808268,"startTime":"0","endTime":"0","summary":"Shares of Liquidia Technologies Inc (LQDA) surged 5.01% during intraday trading on Friday, following a series of positive analyst actions.The stock's upward movement appears to be driven by continued...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2617337684","title":"Liquidia Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2617337684","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617337684?lang=en_us&edition=fundamental","pubTime":"2026-03-06 18:57","pubTimestamp":1772794620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LQDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 05:57 ET (10:57 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2617248577","title":"Liquidia: Strong Yutrepia Uptake and Sustained Profitability Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2617248577","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617248577?lang=en_us&edition=fundamental","pubTime":"2026-03-06 07:55","pubTimestamp":1772754930,"startTime":"0","endTime":"0","summary":"Gaurav Maini, an analyst from LifeSci Capital, has initiated a new Buy rating on Liquidia Technologies (LQDA). Gaurav Maini has given his Buy ratin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/liquidia-strong-yutrepia-uptake-and-sustained-profitability-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/liquidia-strong-yutrepia-uptake-and-sustained-profitability-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2617571904","title":"Liquidia files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2617571904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617571904?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:46","pubTimestamp":1772747178,"startTime":"0","endTime":"0","summary":"16:41 EST Liquidia (LQDA) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2617857368","title":"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Beyond Air (XAIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617857368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617857368?lang=en_us&edition=fundamental","pubTime":"2026-03-06 04:00","pubTimestamp":1772740829,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Liquidia Technologies (LQDA – Research Report) and B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-and-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-and-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","BK4588","XAIR","LU0128526141.USD","XLV","BK4585","XBI","BK4007","LU0029874061.USD","BK4581","LABU","LQDA","BK4082"],"gpt_icon":0},{"id":"2617524825","title":"United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2617524825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617524825?lang=en_us&edition=fundamental","pubTime":"2026-03-06 00:34","pubTimestamp":1772728489,"startTime":"0","endTime":"0","summary":"United Therapeutics  remains a \"top pick\" due to several near- to medium-term catalysts that could drive upside, UBS Securities analysts said in a report Thursday.The firm said upcoming clinical trial data for \"Tyvaso\" in idiopathic pulmonary fibrosis, expected in late March or early April, could lift the stock, particularly if followed by a fast approval and \"accelerated launch,\" and a potential update on the company's intellectual property dispute with Liquidia  is another possible catalyst.The company's \"soft-mist treprostinil inhaler\" announced during Q4 earnings, surprised investors, with its management indicating it could seek regulatory approval based on \"stability and bioequivalence\" data in healthy volunteers and potentially launch the product in 2027, the report said.Analysts also highlighted strong Phase 3 data for \"Ralinepag\" in pulmonary arterial hypertension, could allow the drug to capture market share from Johnson & Johnson's  Uptravi.UBS has a buy rating on United Ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1244550577.SGD","LU2750360641.GBP","UTHR","LU1929549753.HKD","LU2505996509.AUD","IE0034235303.USD","JNJ","IE0002141913.USD","LU1894683264.USD","LU2471134879.HKD","LU1066051811.HKD","LU0640476718.USD","IE00BVYPNV92.GBP","LU0345769631.USD","LU0432979614.USD","LU0058720904.USD","LU1162221912.USD","LU0792757196.USD","IE00BFTCPJ56.SGD","LU1032466523.USD","LU1066051498.USD","LU2602419157.SGD","BK4550","IE00BN8TJ469.HKD","LU1718418525.SGD","LU1244550221.USD","IE00BDGV0183.EUR","LU0203347892.USD","LU0795875086.SGD","LU1894683348.USD","LU2471134796.USD","LU0098860793.USD","LU2133065610.SGD","LU2471134952.CNY","IE00B3PB1722.GBP","LU2089984988.USD","LU2129689514.USD","BK4588","IE00BZ1G4Q59.USD","LU1023059063.AUD","LQDA","LU1674673428.USD","LU0320765646.SGD","LU2468319806.SGD","BK4534","LU0070217475.USD","LU0114720955.EUR","BK4559","IE00B19Z3581.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"1189821899","title":"Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=1189821899","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189821899?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:02","pubTimestamp":1772712162,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.The company reported a significant swing to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"1145112471","title":"Stock Track | Liquidia Technologies Plunges 7.62% in Pre-market After Q4 and Full Year Earnings Miss Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1145112471","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145112471?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:44","pubTimestamp":1772711077,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc (LQDA) experienced a pre-market plunge of 7.62% on Thursday, as investors reacted negatively to the company's latest earnings report.The biopharmaceutical company reported...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2617549329","title":"Liquidia's 2025 EPS misses analyst expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2617549329","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617549329?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:38","pubTimestamp":1772710722,"startTime":"0","endTime":"0","summary":"Liquidia's 2025 EPS misses analyst expectationsOverviewBiopharmaceutical firm's YUTREPIA sales led to second consecutive profitable qtrCompany ended 2025 with $190.7 mln cash, up $33.2 mln from Q3EPS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL1N3ZT0J7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMI","BK4585","LU0154245673.USD","BK4567","BK4533","BK4007","LU0203345920.USD","BK4149","BK4588","LQDA","LU0203347892.USD","LU0154245756.USD"],"gpt_icon":0},{"id":"2617554997","title":"Liquidia reports Q4 EPS 15c, consensus 33c","url":"https://stock-news.laohu8.com/highlight/detail?id=2617554997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617554997?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:37","pubTimestamp":1772710670,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $92.02M, consensus $87.49M. Roger Jeffs, Liquidia’s (LQDA) CEO, said: “As we close 2025, we are encouraged by how quickly YUTREP...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-reports-q4-eps-15c-consensus-33c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-reports-q4-eps-15c-consensus-33c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2617549319","title":"Earnings Flash (LQDA) Liquidia Posts Q4 EPS $0.15, vs. FactSet Est of $0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2617549319","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617549319?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:36","pubTimestamp":1772710613,"startTime":"0","endTime":"0","summary":"Earnings Flash (LQDA) Liquidia Posts Q4 EPS $0.15, vs. FactSet Est of $0.18","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LQDA"],"gpt_icon":0},{"id":"2617460805","title":"Liquidia Q4 net income hits USD 14.6 million as FY SG&A rises 93% to USD 157.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617460805","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617460805?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:31","pubTimestamp":1772710280,"startTime":"0","endTime":"0","summary":"Liquidia said FY 2025 net product sales were USD 148.3 million, including USD 90.1 million in Q4 2025, driven by YUTREPIA following its June 2025 U.S. launch. FY 2025 service revenue, net was USD 10.0 million , primarily related to the Sandoz promotion agreement for Treprostinil Injection. FY 2025 net loss was USD 68.9 million, while Q4 2025 net income was USD 14.6 million; Q4 2025 also delivered positive non-GAAP adjusted EBITDA of USD 27.3 million. Liquidia ended FY 2025 with USD 190.7 million in cash and cash equivalents. On the commercial side, Liquidia reported more than 3,600 unique prescriptions and more than 2,900 patients started on YUTREPIA since launch, with prescription-to-start conversion at or above 85%. The prescriber base rose to about 860. Management said it plans in 2026 to deepen prescriber adoption, grow the sales force, expand YUTREPIA clinical evidence through multiple new studies, and advance L606 into pivotal trials, funded from operations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLHVXM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","BK4112","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","NDAQ","BK4585","IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","IE00BKPKM429.USD","BK4007","BK4588","LQDA"],"gpt_icon":0},{"id":"2617354983","title":"BRIEF-Liquidia FY EPS USD -0.8 Vs. IBES Estimate USD -0.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2617354983","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617354983?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:30","pubTimestamp":1772710245,"startTime":"0","endTime":"0","summary":"BRIEF-Liquidia FY EPS USD -0.8 Vs. IBES Estimate USD -0.76\n\n\nMar 05 (Reuters) - Liquidia FY operating income USD -51.376 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLXBB75BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2617498185","title":"Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2617498185","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617498185?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:30","pubTimestamp":1772710200,"startTime":"0","endTime":"0","summary":"Achieved YUTREPIA net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarterMore than 3,600 unique prescriptions received and 2,900 patients treated to date si","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3249963/0/en/Liquidia-Corporation-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4580","LU2264538146.SGD","BK4588","LU0070302665.USD","PH","LU0211331839.USD","LU0256863902.USD","LU1064131342.USD","LQDA","LU1988902786.USD","LU0256863811.USD","LU0417517546.SGD","LU1989772923.USD","LU0320765489.SGD","LU1989772840.SGD","BK4007","BK4585","LU0208291251.USD","BK4161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0569},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.618},{"period":"1year","weight":1.3479},{"period":"ytd","weight":0.0293}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.021194},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.072031},{"month":5,"riseRate":0.857143,"avgChangeRate":0.14078},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.074968},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.00324},{"month":8,"riseRate":0.5,"avgChangeRate":0.048271},{"month":9,"riseRate":0.375,"avgChangeRate":0.049793},{"month":10,"riseRate":0.625,"avgChangeRate":0.025896},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction